医薬品不足情報を
お知らせください

詳しくはこちら

供給情報モニター施設
（薬局・医療機関）を
募集しています（無償）

詳しくはこちら

海外医薬品の不足情報・医薬政策情報等を
デイリーで発信中

国内不足状況

一覧を見る

諸外国不足状況

  • 2025.11.03 [ ドイツ ]
    BfArMボトルネック・レポート（2025年10月27日～11月2日）
    Active ingredients
    Message type
    		Date of last messageType of reasonAM designation
    NimodipineChange notification31.10.2025OtherNimotop S
    Galantamine hydrobromideChange notification31.10.2025OtherGalantamine – 1A Pharma 24 mg delayed-release hard capsules
    NimodipineInitial report31.10.2025OtherNimotop
    Galantamine hydrobromideChange notification31.10.2025OtherGalantamine – 1A Pharma 16 mg delayed-release hard capsules
    Sertraline hydrochlorideInitial report31.10.2025OtherZoloft 20 mg/ml concentrate for oral solution
    Ciprofloxacin hydrochloride monohydrateChange notification30.10.2025OtherCIPRO BASICS 750 mg film-coated tablets
    Ciprofloxacin hydrochloride monohydrateChange notification30.10.2025OtherCIPRO BASICS 250 mg film-coated tablets
    Atorvastatin calcium trihydrate (Ph.Eur.)Change notification30.10.2025OtherATORVASTATIN BASICS 80 mg film-coated tablets
    Ezetimibe; simvastatinChange notification30.10.2025Production problemEZETIMIB/SIMVA BASICS 10 mg/80 mg tablets
    Ezetimibe; simvastatinChange notification30.10.2025Production problemEZETIMIB/SIMVA BASICS 10 mg/40 mg tablets
    Ezetimibe; simvastatinChange notification30.10.2025Production problemEZETIMIB/SIMVA BASICS 10 mg/20 mg tablets
    Ezetimibe; simvastatinChange notification30.10.2025Production problemEZETIMIBE/SIMVA BASICS 10 mg/10 mg tablets
    Esomeprazole hemimagnesiumChange notification30.10.2025Production problemESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules
    Esomeprazole hemimagnesiumChange notification30.10.2025Production problemESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules
    IsotretinoinChange notification30.10.2025OtherISOTRETINOIN BASICS 10 mg soft capsules
    Isophan insulin suspension for injection (Ph.Eur.)Initial report30.10.2025OtherProtaphane Penfill 100 IU/ml injection suspension in cylinder ampoule – OP(10x3ml)
    Flecainide acetateChange notification30.10.2025OtherTambocor
    Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x)))Change notification30.10.2025OtherMoxifloxacin Holsten 400 mg film-coated tablets
    Doxepin hydrochloride (Ph.Eur.)Initial report30.10.2025OtherDoxepin 50 Holsten
    AlprazolamChange notification30.10.2025OtherAlprazolam – 1 A Pharma 1 mg tablets
    OxcarbazepineChange notification30.10.2025OtherOxcarbazepine – 1 A Pharma 60 mg/ml oral suspension
    FlutamideChange notification30.10.2025Production problemFLUTA-cell 250 mg tablets
    VoriconazoleInitial report29.10.2025OtherVFEND 200 mg film-coated tablets
    Doxepin hydrochloride (Ph.Eur.)Change notification29.10.2025OtherDoxepin 75 Holsten
    Doxepin hydrochloride (Ph.Eur.)Change notification29.10.2025Production problemDoxepin 25 Holsten
    Methylphenidate hydrochlorideChange notification29.10.2025OtherMethylphenidate AL 36 mg prolonged-release tablets
    Methylphenidate hydrochlorideChange notification29.10.2025OtherMetiphenal 10 mg modified-release hard capsules
    PosaconazoleChange notification29.10.2025OtherPosaconazole AL 40 mg/ml oral suspension
    Methylphenidate hydrochlorideChange notification29.10.2025OtherMethylphenidate AL 27 mg prolonged-release tablets
    AprepitantChange notification29.10.2025OtherAprepitant AL 80 mg hard capsules
    Levothyroxine sodiumChange notification28.10.2025Production problemL-thyroxine Henning 125
    (4′-O-(13)C)MethacetinChange notification28.10.2025Production problemLiMAxetin 4 mg/ml solution for injection
    BesilesomabInitial report28.10.2025Production problemScintimun
    BesilesomabInitial report28.10.2025Production problemScintimun
    LevetiracetamChange notification28.10.2025OtherLevetiracetam – 1 A Pharma 1500 mg film-coated tablets
    Olanzapine embonate monohydrateInitial report28.10.2025Production problemZYPADHERA 210 mg powder and solvent for the preparation of a prolonged-release suspension for injection – OP(483mg+3ml)
    Paliperidone palmitateInitial report28.10.2025OtherPaliperidone AL 25 mg prolonged-release injection suspension in a pre-filled syringe
    Paliperidone palmitateChange notification28.10.2025OtherPaliperidone AL 50 mg depot injection suspension in a pre-filled syringe
    OlanzapineChange notification28.10.2025Production problemZYPREXA
    Fluphenazine decanoateChange notification28.10.2025Production problemFluphenazine-neuraxpharm D 50 mg/0.5 ml
    Fluphenazine decanoateChange notification28.10.2025Production problemFluphenazine-neuraxpharm D 12.5 mg/0.5 ml
    Fluphenazine decanoateChange notification28.10.2025Production problemFluphenazine-neuraxpharm D 25 mg/ml
    Fluphenazine decanoateChange notification28.10.2025Production problemFluphenazine-neuraxpharm D 100 mg/ml
    Atomoxetine hydrochlorideChange notification28.10.2025Production problemAtomoxetine-neuraxpharm 60 mg hard capsules
    Atomoxetine hydrochlorideChange notification28.10.2025Production problemAtomoxetine-neuraxpharm 10 mg hard capsules
    Atomoxetine hydrochlorideChange notification28.10.2025Production problemAtomoxetine-neuraxpharm 18 mg hard capsules
    Atomoxetine hydrochlorideChange notification28.10.2025Production problemAtomoxetine-neuraxpharm 25 mg hard capsules
    Atomoxetine hydrochlorideChange notification28.10.2025Production problemAtomoxetine-neuraxpharm 40 mg hard capsules
    Atomoxetine hydrochlorideChange notification28.10.2025Production problemAtomoxetine-neuraxpharm 80 mg hard capsules
    Atomoxetine hydrochlorideChange notification28.10.2025Production problemAtomoxetine-neuraxpharm 100 mg hard capsules
    Haloperidol decanoateChange notification28.10.2025Production problemHaloperidol-neuraxpharm decanoate 50 mg/ml
    Haloperidol decanoateChange notification28.10.2025Production problemHaloperidol-neuraxpharm decanoate 100 mg/ml
    Quetiapine fumarate (Ph.Eur.)Change notification28.10.2025OtherQuetiapine-neuraxpharm 50 mg prolonged-release tablets
    Quetiapine fumarate (Ph.Eur.)Change notification28.10.2025OtherQuetiapine-neuraxpharm 150 mg prolonged-release tablets
    FlutamideChange notification28.10.2025OtherFlutamide AL 250
    Quetiapine fumarate (Ph.Eur.)Change notification28.10.2025OtherQuetiapine-neuraxpharm 200 mg prolonged-release tablets
    Quetiapine fumarate (Ph.Eur.)Change notification28.10.2025OtherQuetiapine-neuraxpharm 300 mg prolonged-release tablets
    Quetiapine fumarate (Ph.Eur.)Change notification28.10.2025OtherQuetiapine-neuraxpharm 400 mg prolonged-release tablets
    Quetiapine fumarate (Ph.Eur.)Change notification28.10.2025OtherQuetiapine-neuraxpharm 600 mg prolonged-release tablets
    Biperiden hydrochlorideChange notification28.10.2025Production problemBiperiden-neuraxpharm 2 mg
    Biperiden hydrochlorideChange notification28.10.2025Production problemBiperiden-neuraxpharm 4 mg
    Methylphenidate hydrochlorideChange notification28.10.2025OtherMethylphenidate hydrochloride-neuraxpharm 27 mg prolonged-release tablets
    Sodium (methylprednisolone-21-succinate)Change notification28.10.2025OtherUrbason soluble forte 1000 mg
    Isosorbide mononitrateChange notification28.10.2025Production problemISMN STADA 50 mg hard capsules, delayed release
    AprepitantChange notification28.10.2025Production problemAprepitant STADA 125 mg and 80 mg hard capsules
    Pramipexole dihydrochloride monohydrateChange notification28.10.2025Production problemPramipexole STADA 0.52 mg prolonged-release tablets
    AprepitantChange notification28.10.2025Production problemAprepitant STADA 80 mg hard capsules
    AprepitantChange notification28.10.2025Production problemAprepitant STADA 125 mg hard capsules
    GabapentinChange notification27.10.2025OtherGabapentin Holsten 100 mg hard capsules
    TetrabenazineInitial report27.10.2025OtherTetrabenazine Aristo 25 mg tablets
    Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y)Change notification27.10.2025OtherFerrlecit 62.5 mg
    Cefaclor monohydrateChange notification27.10.2025OtherCefaclor 125 TS – 1 A Pharma
    Methyldopa (Ph.Eur.)Change notification27.10.2025OtherDopegyt tablets
    Insulin glargineChange notification27.10.2025OtherSemglee 100 units/ml solution for injection in pre-filled pen – OP(5x3ml)
    Sufentanil citrateInitial report27.10.2025Production problemSufenta mite
    Arsenic(III) oxideChange notification27.10.2025Production problemArsenic trioxide STADA 1 mg/ml concentrate for solution for infusion
  • 2025.11.03 [ フランス ]
    ANSMフランス供給不足情報（2025年10月27日～11月2日）
    Active ingredientsStatutUpdateSpecialty
    caffeine, opium (dry extract of), paracetamolSupply tension31/10/2025Lamaline, suppository
    mesalazineSupply tension31/10/2025Pentasa 1 g and 2 g, granules in sachets, and Pentasa 1 g, suppositories
    demeclocycline hydrochlorideStock shortage31/10/2025Alkonatrem 150 mg, capsule
    Immunoglobuline humaine rabiqueMarketing discontinuation31/10/2025Imogam Rage 150 UI/mL, solution injectable
    clarithromycinReturn to availability31/10/2025Clarithromycin, 250 and 500 mg, modified-release film-coated tablet and film-coated tablet
    clarithromycinReturn to availability31/10/2025Clarithromycin Arrow 25 mg/mL, granules for oral suspension
    clarithromycinReturn to availability31/10/2025Clarithromycin 50 mg/mL, granules for oral suspension
    Return to availability31/10/2025Copper 6 mg/1 mL  Histidine 117.20 mg/3 mL AP-HP, injectable solution, CIPH code 77772737
    chlorpromazine (hydrochloride)Stock shortage31/10/2025Largactil 100 mg, film-coated tablet
    acide ascorbiqueSupply tension10/30/2025Laroscorbine 1 g/5 ml, solution injectable I.V. en ampoule
    tobramycinSupply tension10/30/2025Tobi Podhaler 28 mg, powder for inhalation in capsules
    cytarabineReturn to availability10/30/2025Cytarabine Sandoz 100 mg/mL, solution for injection – 1 glass vial(s) of 50 mL
    varenicline (tartrate)Supply tension10/30/2025Champix 0.5 mg and 1 mg, film-coated tablet
    fluorouracilSupply tension29/10/2025Fluorouracil Accord 50 mg/mL, solution for dilution for infusion, 5 mL and 100 mL vials
    methylprednisolone (sodium hydrogen succinate)Return to availability29/10/2025Methylprednisolone Hikma 40 mg, powder for solution for injection
    lithium (carbonate)Supply tension29/10/2025Teralithe 250 mg, breakable tablet
    lithium (carbonate)Supply tension29/10/2025Teralithe LP 400 mg, extended-release breakable tablet
    bromfenac sodium sesquihydrateSupply tension28/10/2025Yellox 0.9 mg/mL, eye drops, solution
    epoetin betaSupply tension28/10/2025NeoRecormon range, injectable solution in pre-filled syringe
    temozolomideSupply tension28/10/2025Temodal 2.5 mg/mL, powder for solution for infusion
    methylprednisolone (sodium hydrogen succinate)Supply tension28/10/2025Methylprednisolone Hikma 500 mg, powder for solution for injection
    tolvaptanSupply tension27/10/2025Jinarc 15 mg tablet + Jinarc 45 mg tablet
    tolvaptanStock shortage27/10/2025Tolvaptan Teva 15 mg tablet + Tolvaptan Teva 45 mg tablet
    cyanocobalaminSupply tension27/10/2025Vitamin B12 Delagrange 1000 micrograms/2 mL, injectable (IM) and oral solution
    tolvaptanStock shortage27/10/2025Tolvaptan Biogaran 15 mg, tablet + Tolvaptan Biogaran 45 mg, tablet
  • 2025.11.03 [ オーストラリア ]
    TGAオーストラリア供給不足情報（2025年10月27日～11月2日）
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    clozapineOral Liquid, suspension50 mg/mLCurrentUnavailableManufacturing3/11/2025
    pramipexole dihydrochloride monohydrateTablet1 mgAnticipatedAvailableManufacturing3/11/2025
    pramipexole dihydrochloride monohydrateTablet1 mgAnticipatedAvailableManufacturing3/11/2025
    bleomycin sulfateInjection, powder for15000 IUAnticipatedAvailableManufacturing3/11/2025
    pramipexole dihydrochloride monohydrateTablet, uncoated1 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply3/11/2025
    pramipexole dihydrochloride monohydrateTablet, uncoated.125 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply3/11/2025
    saxagliptin~dapagliflozin propanediol monohydrateTablet5 mg~12.3 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability1/11/2025
    dinoprostoneGel.3333 mg/gAnticipatedAvailableManufacturing1/11/2025
    betiatideInjection, powder for1 mgAnticipatedAvailableManufacturing31/10/2025
    phenylephrine hydrochlorideInjection, solution10 mg/mLAnticipatedAvailableManufacturing31/10/2025
    phenoxymethylpenicillin potassiumOral Liquid, powder for28.284 mg/mLResolvedAvailableManufacturing31/10/2025
    pramipexole dihydrochloride monohydrateTablet.125 mgCurrentUnavailableManufacturing31/10/2025
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrentUnavailableManufacturing31/10/2025
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues31/10/2025
    pramipexole dihydrochloride monohydrateTablet.125 mgCurrentUnavailableManufacturing31/10/2025
    bisoprolol fumarateTablet2.5 mgResolvedAvailableManufacturing31/10/2025
    phenobarbitalTablet, uncoated30 mgCurrentLimited AvailabilityManufacturing31/10/2025
    escitalopram oxalateTablet, film coated25.548 mgCurrentLimited AvailabilityManufacturing31/10/2025
    pramipexole dihydrochloride monohydrateTablet.125 mgCurrentUnavailableUnexpected increase in consumer demand31/10/2025
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrentUnavailableUnexpected increase in consumer demand31/10/2025
    bimatoprostEye Drops.3 mg/mLCurrentUnavailableManufacturing31/10/2025
    linezolidTablet, film coated600 mgCurrentUnavailableManufacturing31/10/2025
    irbesartanTablet, film coated300 mgAnticipatedAvailableManufacturing31/10/2025
    irbesartanTablet, film coated150 mgAnticipatedAvailableManufacturing31/10/2025
    tranexamic acidTablet, film coated500 mgCurrentUnavailableManufacturing31/10/2025
    olmesartan medoxomil~amlodipine besilateTablet, film coated20 mg~6.935 mgAnticipatedAvailableManufacturing31/10/2025
    rasagiline mesilateTablet1.56 mgCurrentLimited AvailabilityManufacturing31/10/2025
    rasagiline mesilateTablet1.56 mgCurrentUnavailableManufacturing31/10/2025
    ambrisentanTablet, film coated5 mgCurrentLimited AvailabilityManufacturing31/10/2025
    lorazepamTablet1 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply31/10/2025
    hyoscine butylbromideInjection, solution20 mgCurrentLimited AvailabilityManufacturing31/10/2025
    daptomycinInjection, powder for500 mgCurrentLimited AvailabilityManufacturing31/10/2025
    fentanyl citrateInjection, solution785 microgramResolvedAvailableManufacturing31/10/2025
    famciclovirTablet, film coated250 mgResolvedAvailableManufacturing31/10/2025
    famciclovirTablet, film coated500 mgResolvedAvailableManufacturing31/10/2025
    lidocaine hydrochloride monohydrateInjection, solution10 mg/mLResolvedAvailableManufacturing31/10/2025
    lidocaine hydrochloride monohydrateInjection, solution10 mg/mLCurrentLimited AvailabilityManufacturing31/10/2025
    pramipexole dihydrochloride monohydrateTablet, uncoated.25 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply31/10/2025
    lamotrigineTablet, dispersible200 mgAnticipatedAvailableManufacturing31/10/2025
    rifampicinOral Liquid20 mg/mLAnticipatedAvailableUnexpected increase in consumer demand30/10/2025
    galantamine hydrobromideCapsule, modified release20.512 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply30/10/2025
    mesalazineTablet, modified release1 gResolvedAvailableTransport / Logistic issues / Storage capacity issues30/10/2025
    lansoprazoleCapsule, enteric30 mgCurrentLimited AvailabilityManufacturing30/10/2025
    ondansetron hydrochloride dihydrateTablet, film coated9.972 mgCurrentLimited AvailabilityManufacturing30/10/2025
    metronidazoleTablet, uncoated400 mgCurrentLimited AvailabilityManufacturing30/10/2025
    naproxenOral Liquid, suspension25 mg/mLResolvedAvailableManufacturing30/10/2025
    risperidoneTablet, film coated3 mgCurrentLimited AvailabilityManufacturing30/10/2025
    quetiapine fumarateTablet, modified release345.39 mgAnticipatedAvailableManufacturing30/10/2025
    pramipexole dihydrochloride monohydrateTablet, modified release.75 mgResolvedAvailableManufacturing30/10/2025
    pramipexole dihydrochloride monohydrateTablet, modified release.375 mgResolvedAvailableManufacturing30/10/2025
    pramipexole dihydrochloride monohydrateTablet, modified release1.5 mgResolvedAvailableManufacturing30/10/2025
    pramipexole dihydrochloride monohydrateTablet, modified release2.25 mgResolvedAvailableManufacturing30/10/2025
    hydrochlorothiazide~irbesartanTablet, film coated12.5 mg~300 mgResolvedAvailableManufacturing30/10/2025
    atenololTablet, film coated50 mgResolvedAvailableManufacturing30/10/2025
    latanoprostEye Drops, solution.05 mg/mLAnticipatedAvailableManufacturing30/10/2025
    erlotinib hydrochlorideTablet, film coated27.32 mgCurrentUnavailableUnexpected increase in consumer demand30/10/2025
    carvedilolTablet, film coated6.25 mgResolvedAvailableManufacturing30/10/2025
    thiotepaInjection, powder for15 mgCurrentUnavailableCommercial Changes / Commercial viability30/10/2025
    thiotepaInjection, powder for100 mgCurrentUnavailableCommercial Changes / Commercial viability30/10/2025
    thiotepaInjection, powder for400 mgCurrentUnavailableCommercial Changes / Commercial viability30/10/2025
    TeriparatideInjection, solution.25 mg/mLResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply30/10/2025
    phenytoin sodiumInjection, solution250 mgCurrentLimited AvailabilityManufacturing30/10/2025
    mianserin hydrochlorideTablet, film coated20 mgCurrentLimited AvailabilityManufacturing30/10/2025
    methyldopa sesquihydrateTablet, film coated283 mgCurrentLimited AvailabilityManufacturing30/10/2025
    pamidronate disodiumInjection, concentrated3 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/10/2025
    nizatidineCapsule300 mgAnticipatedAvailableManufacturing30/10/2025
    simvastatinTablet, film coated5 mgAnticipatedAvailableManufacturing30/10/2025
    verapamil hydrochloride~trandolaprilTablet, film coated240 mg~4 mgResolvedAvailableManufacturing29/10/2025
    calcium polystyrene sulfonatePowder999.3 mg/gAnticipatedAvailableManufacturing29/10/2025
    risperidoneTablet, film coated1 mgResolvedAvailableManufacturing29/10/2025
    pentetic acidInjection, powder for5 mgCurrentUnavailableManufacturing29/10/2025
    medronic acidInjection, powder for10 mgCurrentUnavailableManufacturing29/10/2025
    sildenafil citrateTablet, uncoated35.1 mgResolvedAvailableManufacturing29/10/2025
    clopidogrel hydrogen sulfateTablet, film coated97.875 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/10/2025
    ceftazidime pentahydrateInjection, powder for2.328 gCurrentLimited AvailabilityManufacturing29/10/2025
    methylphenidate hydrochlorideCapsule, modified release10 mgCurrentLimited AvailabilityManufacturing29/10/2025
    clopidogrel hydrogen sulfateTablet, film coated97.9 mgCurrentUnavailableUnexpected increase in consumer demand29/10/2025
    temozolomideCapsule, hard5 mgCurrentLimited AvailabilityManufacturing29/10/2025
    sodium nitroprussideInjection, solution50 mgAnticipatedAvailableManufacturing29/10/2025
    tobramycinCapsule, hard28 mgAnticipatedAvailableManufacturing29/10/2025
    lansoprazoleTablet, orally disintegrating30 mgCurrentLimited AvailabilityManufacturing29/10/2025
    atorvastatin calcium trihydrate~amlodipine besilateTablet, film coated43.376 mg~13.88 mgCurrentLimited AvailabilityManufacturing29/10/2025
    phenoxymethylpenicillin potassiumTablet, film coated560 mgCurrentLimited AvailabilityManufacturing29/10/2025
    rosuvastatin calciumTablet, film coated41.68 mgCurrentUnavailableManufacturing29/10/2025
    pregabalinCapsule, hard75 mgResolvedAvailableManufacturing29/10/2025
    methylphenidate hydrochlorideCapsule, modified release60 mgCurrentLimited AvailabilityManufacturing29/10/2025
    mesalazineTablet, enteric coated800 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues29/10/2025
    hydrocortisoneTablet, uncoated4 mgCurrentLimited AvailabilityManufacturing29/10/2025
    tadalafilTablet, film coated5 mgResolvedAvailableManufacturing29/10/2025
    risperidoneTablet, film coated.5 mgAnticipatedAvailableCommercial Changes / Commercial viability29/10/2025
    risperidoneTablet, film coated1 mgCurrentUnavailableCommercial Changes / Commercial viability29/10/2025
    risperidoneTablet, film coated2 mgCurrentUnavailableCommercial Changes / Commercial viability29/10/2025
    risperidoneTablet, film coated3 mgCurrentUnavailableCommercial Changes / Commercial viability29/10/2025
    risperidoneTablet, film coated4 mgCurrentUnavailableCommercial Changes / Commercial viability29/10/2025
    fluorouracilInjection, solution50 mg/mLResolvedAvailableUnexpected increase in consumer demand29/10/2025
    benzathine benzylpenicillin tetrahydrateInjection, suspension600000 USP UnitCurrentUnavailableManufacturing29/10/2025
    lurasidone hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing29/10/2025
    lurasidone hydrochlorideTablet, film coated80 mgResolvedAvailableManufacturing29/10/2025
    amiodarone hydrochlorideTablet, uncoated100 mgResolvedAvailableManufacturing29/10/2025
    spironolactoneTablet, uncoated100 mgResolvedAvailableManufacturing29/10/2025
    lenalidomideCapsule5 mgResolvedAvailableManufacturing29/10/2025
    sugammadex sodiumInjection, solution217.6 mgResolvedAvailableManufacturing29/10/2025
    hydrocortisone hydrogen succinateInjection, powder for127.6 mgAnticipatedAvailableManufacturing29/10/2025
    levothyroxine sodiumTablet50 microgramResolvedAvailableUnexpected increase in consumer demand29/10/2025
    levothyroxine sodiumTablet100 microgramResolvedAvailableUnexpected increase in consumer demand29/10/2025
    sodium chlorideInjection, intravenous infusion9 g/LCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply29/10/2025
    dorzolamide hydrochlorideEye Drops, solution22.26 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability29/10/2025
    labetalol hydrochlorideTablet, film coated100 mgCurrentUnavailableManufacturing29/10/2025
    methylphenidate hydrochlorideCapsule, modified release20 mgCurrentUnavailableManufacturing29/10/2025
    methylphenidate hydrochlorideCapsule, modified release30 mgCurrentUnavailableManufacturing29/10/2025
    methylphenidate hydrochlorideCapsule, modified release40 mgCurrentUnavailableManufacturing29/10/2025
    amoxicillin sodiumInjection, powder for1060 mgResolvedAvailableManufacturing29/10/2025
    Rubella virus~Measles virus~live varicella vaccine~Mumps virusInjection, powder for1000 CCID50~1000 CCID50~1995 PFU~25119 CCID50ResolvedAvailableManufacturing28/10/2025
    prazosin hydrochlorideTablet, uncoated2.19 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply28/10/2025
    prazosin hydrochlorideTablet, uncoated5.476 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply28/10/2025
    salbutamol sulfateInhalation, conventional6 mgCurrentUnavailableManufacturing28/10/2025
    stannous chloride~etifeninInjection, powder for.42 mg~20 mgCurrentUnavailableManufacturing28/10/2025
    SomatropinInjection, powder for12 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand28/10/2025
    hydrocortisone sodium succinateInjection, powder for134 mgResolvedAvailableManufacturing28/10/2025
    enalapril maleateTablet5 mgCurrentLimited AvailabilityManufacturing28/10/2025
    alfentanil hydrochlorideInjection, solution1.0876 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues28/10/2025
    doxylamine succinateTablet, uncoated25 mgCurrentLimited AvailabilityUnexpected increase in consumer demand28/10/2025
    quetiapine fumarateTablet, modified release57.5 mgAnticipatedAvailableUnexpected increase in consumer demand28/10/2025
    peramivirInjection, concentrated10 mg/mLAnticipatedAvailableCommercial Changes / Commercial viability28/10/2025
    topotecan hydrochlorideInjection, concentrated4.346 mgCurrentLimited AvailabilityUnexpected increase in consumer demand28/10/2025
    stannous chloride dihydrateInjection, powder for19.2 microgram/mLResolvedAvailableManufacturing28/10/2025
    Interferon gamma1bInjection, solution4 million IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability28/10/2025
    risperidoneInjection, modified release50 mgAnticipatedAvailableManufacturing28/10/2025
    Insulin glulisineInjection, solution3.49 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability28/10/2025
    lidocaine hydrochlorideInjection, solution10 mg/mLResolvedAvailableManufacturing27/10/2025
    simvastatin~ezetimibeTablet80 mg~10 mgAnticipatedAvailableManufacturing27/10/2025
    ezetimibe~simvastatinTablet10 mg~40 mgAnticipatedAvailableManufacturing27/10/2025
    donepezil hydrochlorideTablet, film coated5 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply27/10/2025
    cyproterone acetateTablet, uncoated100 mgAnticipatedAvailableManufacturing27/10/2025
    fluorouracilInjection, solution50 mg/mLCurrentUnavailableManufacturing27/10/2025
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated10.341 mg~10 mgResolvedAvailableManufacturing27/10/2025
    emtricitabine~tenofovir disoproxil succinateTablet, film coated200 mg~300.6 mgCurrentLimited AvailabilityManufacturing27/10/2025
    pentamidine isetionateInjection, powder for300 mgAnticipatedAvailableManufacturing27/10/2025
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing27/10/2025
    GluureaLys(ahx)hbedCCInjection, powder for25 microgramCurrentUnavailableManufacturing27/10/2025
    GluureaLys(ahx)hbedCCInjection, powder for25 microgramCurrentUnavailableManufacturing27/10/2025
    iotroxate meglumineInjection, solution105.46 mg/mLResolvedAvailableTransport / Logistic issues / Storage capacity issues27/10/2025
    galantamine hydrobromide~galantamineCapsule, modified release20.51 mg~16 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply27/10/2025
  • 2025.11.03 [ 米国 ]
    ASHP供給不足情報（2025年10月27日～11月2日）
    Generic NameShortage StatusRevision Date
    Dexamethasone Sodium Phosphate InjectionCurrent Shortages30-Oct-25
    Eptifibatide InjectionCurrent Shortages30-Oct-25
    Hydrocodone and Acetaminophen TabletsCurrent Shortages30-Oct-25
    Ibandronate Sodium InjectionCurrent Shortages30-Oct-25
    Linezolid InjectionCurrent Shortages30-Oct-25
    Liraglutide InjectionCurrent Shortages30-Oct-25
    Morphine Sulfate Extended-Release TabletsCurrent Shortages30-Oct-25
    Morphine Sulfate Immediate-Release TabletsCurrent Shortages30-Oct-25
    Hydrocortisone Sodium Succinate InjectionCurrent Shortages29-Oct-25
    Amphetamine Extended-Release Oral PresentationsCurrent Shortages28-Oct-25
    Cefdinir Oral PresentationsCurrent Shortages28-Oct-25
    Clindamycin Phosphate InjectionCurrent Shortages28-Oct-25
    Clonazepam Oral TabletsCurrent Shortages28-Oct-25
    Dexamethasone Oral Solution/ElixirCurrent Shortages28-Oct-25
    Dicyclomine Oral PresentationsCurrent Shortages28-Oct-25
    Dobutamine InjectionCurrent Shortages28-Oct-25
    Etomidate InjectionCurrent Shortages28-Oct-25
    Fentanyl Citrate InjectionCurrent Shortages28-Oct-25
    Hydromorphone Hydrochloride InjectionCurrent Shortages28-Oct-25
    Minoxidil 2.5 mg TabletsCurrent Shortages28-Oct-25
    Mometasone Furoate and Formoterol Fumarate Inhalation AerosolCurrent Shortages28-Oct-25
    Alteplase InjectionResolved Shortages27-Oct-25
    Sterile TalcCurrent Shortages27-Oct-25
  • 2025.11.03 [ 米国 ]
    FDA供給不足情報：新規・更新（2025年10月27日～11月2日）
    New

    October 31, 2025

    October 29, 2025

    October 27, 2025

     

    Updated

    期間中、新たな報告はありません。

一覧を見る

供給関連情報

一覧を見る

医薬政策情報

一覧を見る

NEWS

一覧を見る

製薬会社、研究者、医療機関
の皆さまへ

賛助会員になると、さらに詳しい医薬情報の提供、共同研究、コンサルティングなど、当法人の専門的なサポートが受けられます。

賛助会員の詳細・お申込みはこちら
このページの先頭へ戻る